The President announced a deal to cap the prices of weight-loss drugs like Wegovy and Zepbound for some Medicare recipients.

Eli Lilly and Novo Nordisk officials have agreed to lower the cost of GLP-1 obesity drugs for Medicaid and Medicare ...

While the SNAP freeze has been at the forefront of the federal government shutdown, West Kentucky Allied Services highlights ...

President Donald Trump's administration confirmed Thursday that it has reached a deal with drugmakers Eli Lilly and Novo Nordisk that aims to deliver lower prices for their popular GLP-1 drugs to ...

The Trump administration on Thursday announced a much-anticipated deal with drugmakers Eli Lilly and Novo Nordisk that aims to deliver lower prices for their popular GLP-1 drugs to certain Medicare ...

As Veteran’s Day approaches, officials are shedding light on how we can better protect our veterans after they take off their ...

MURFREESBORO, TN / ACCESS Newswire / November 6, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today that it ...

President Trump on Thursday announced a deal with pharmaceutical giants Novo Nordisk and Eli Lilly to expand coverage and ...

Eli Lilly and Company today announced an agreement with the U.S. government to expand access to its obesity medicines and reduce patient costs. The agreement builds on Lilly's longstanding commitment ...

Higher reimbursement, regulatory clarity, and acknowledgment of future indication expansion expected to reinforce physician confidence and support continued expansion ...

Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year period Third Quarter Net income was $14.1 million compared to Net ...

Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted ...